SCHEMBL30744086

SCHEMBL30744086

O=C(O)C1CC(OCCOc2ccc(-c3cc(=O)c4ccc(Cl)c(Cl)c4o3)cc2)C1

nearest known ligand 0.42

Predicted protein targets (top 11)

geneUniProtsupporting neighboursconfidence
▸ ALDH2 P05091 1/20 0.41
▸ MAOA P21397 1/20 0.41
▸ MAOB P27338 1/20 0.41
▸ ABCB1 P08183 2/20 0.40
▸ ABCG2 Q9UNQ0 2/20 0.39
▸ SIGMAR1 Q99720 3/20 0.38
▸ ABCC1 P33527 1/20 0.38
▸ CYSLTR1 Q9Y271 1/20 0.38
▸ S1PR1 P21453 1/20 0.38
▸ S1PR3 Q99500 1/20 0.38
▸ TERT O14746 1/20 0.38

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL21801085 1.00 ALDH2 (0.41) ALDH2MAOAMAOBABCB1ABCG2
SCHEMBL29180250 0.92 MAOB (0.43) ALDH2MAOAMAOBABCB1ABCG2
SCHEMBL21801231 0.92 MAOB (0.43) ALDH2MAOAMAOBABCB1ABCG2
SCHEMBL21801269 0.91 ABCG2 (0.42) ALDH2MAOAMAOBABCB1ABCG2
SCHEMBL21801083 0.90 CYSLTR1 (0.45) ALDH2MAOAMAOBABCB1SIGMAR1
SCHEMBL21801081 0.90 CYSLTR1 (0.45) ALDH2MAOAMAOBABCB1SIGMAR1
SCHEMBL21801191 0.90 CYSLTR1 (0.45) ALDH2MAOAMAOBABCB1SIGMAR1
SCHEMBL21801239 0.89 ALDH2 (0.41) ALDH2MAOAMAOBABCB1ABCG2
SCHEMBL21801214 0.89 CYP3A4 (0.44) ALDH2MAOAMAOBABCB1ABCG2
SCHEMBL21801084 0.89 ABCG2 (0.39) ALDH2MAOAMAOBABCB1ABCG2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-112601743-B Flavone compounds for the treatment and prevention of hepatitis b virus diseases 豪夫迈·罗氏有限公司 2023-12-19 — — CN claimed
CN-112601743-B Flavone compounds for the treatment and prevention of hepatitis b virus diseases 豪夫迈·罗氏有限公司 2023-12-19 — — CN disclosed
Send feedback